DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Disselhorst MJ, Quispel-Janssen J, Lalezari F. et al.
Ipilimumab and nivolumab in the treatment of recurrent malignant pleural mesothelioma (INITIATE): results of a prospective, single-arm, phase 2 trial.
Lancet Respir Med 2019;
7: 260-270
DOI: 10.1016/S2213-2600(18)30420-X.
We do not assume any responsibility for the contents of the web pages of other providers.